Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials.
Front Pharmacol
; 14: 1145587, 2023.
Article
en En
| MEDLINE
| ID: mdl-37397500
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Idioma:
En
Revista:
Front Pharmacol
Año:
2023
Tipo del documento:
Article
País de afiliación:
China